Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-013596
Filing Date
2025-02-04
Accepted
2025-02-04 16:40:14
Documents
1
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3957
  Complete submission text file 0000950170-25-013596.txt   5504
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ADICET BIO, INC. 131 DARTMOUTH STREET, 3RD FLOOR BOSTON, MA 02116
Business Address
Maltzman Julia D. (Reporting) CIK: 0002052749 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 25588968